Anebulo Pharmaceuticals Financials
| ANEB Stock | USD 2.90 0.15 5.45% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 40.06 | 24.2 |
|
|
The financial analysis of Anebulo Pharmaceuticals is a critical element in measuring its lifeblood. The essential information of the day-to-day investment outlook for Anebulo Pharmaceuticals includes many different criteria found on its balance sheet. For example, investors should never minimize Anebulo Pharmaceuticals' ability to pay suppliers or employees on time, making sure interest payments are not accumulating or correctly timing where and how to re-invest extra cash. Any individual investor needs to monitor Anebulo Pharmaceuticals' cash flow, debt, and profitability to effectively and accurately make more informed decisions on whether to invest in Anebulo Pharmaceuticals.
Net Income |
|
With this module, you can analyze Anebulo financials for your investing period. You should be able to track the changes in Anebulo Pharmaceuticals individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Anebulo | Select Account or Indicator |
Understanding current and past Anebulo Pharmaceuticals Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Anebulo Pharmaceuticals' financial statements are interrelated, with each one affecting the others. For example, an increase in Anebulo Pharmaceuticals' assets may result in an increase in income on the income statement.
The data published in Anebulo Pharmaceuticals' official financial statements usually reflect Anebulo Pharmaceuticals' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Anebulo Pharmaceuticals. For example, before you start analyzing numbers published by Anebulo accountants, it's critical to develop an understanding of what Anebulo Pharmaceuticals' liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Anebulo Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Anebulo Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Anebulo Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Anebulo Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Anebulo Pharmaceuticals' management manipulating its earnings.
Anebulo Pharmaceuticals Stock Summary
Anebulo Pharmaceuticals competes with Invesco Trust, LSI Industries, American Funds, and Merck. Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. The company was incorporated in 2020 and is based in Lakeway, Texas. Anebulo Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US0345691036 |
| CUSIP | 034569103 |
| Location | Texas; U.S.A |
| Business Address | 1017 Ranch Road |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | NYSE Composite |
| Website | www.anebulo.com |
| Phone | (512) 598 0931 |
| Currency | USD - US Dollar |
You should never invest in Anebulo Pharmaceuticals without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Anebulo Stock, because this is throwing your money away. Analyzing the key information contained in Anebulo Pharmaceuticals' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Anebulo Pharmaceuticals Key Financial Ratios
Generally speaking, Anebulo Pharmaceuticals' financial ratios allow both analysts and investors to convert raw data from Anebulo Pharmaceuticals' financial statements into concise, actionable information that can be used to evaluate the performance of Anebulo Pharmaceuticals over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Anebulo Pharmaceuticals reports annually and quarterly.| Return On Equity | -0.95 | ||||
| EBITDA | (11.78 M) | ||||
| Net Income | (11.73 M) |
Anebulo Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Anebulo Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Anebulo Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Anebulo Pharmaceuticals competition to find correlations between indicators driving Anebulo Pharmaceuticals's intrinsic value. More Info.Anebulo Pharmaceuticals is rated second in return on equity category among related companies. It is rated second in return on asset category among related companies . At present, Anebulo Pharmaceuticals' Return On Equity is projected to slightly decrease based on the last few years of reporting.Comparative valuation analysis is a catch-all model that can be used if you cannot value Anebulo Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Anebulo Pharmaceuticals' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Anebulo Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Anebulo Pharmaceuticals Systematic Risk
Anebulo Pharmaceuticals' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Anebulo Pharmaceuticals volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Anebulo Pharmaceuticals correlated with the market. If Beta is less than 0 Anebulo Pharmaceuticals generally moves in the opposite direction as compared to the market. If Anebulo Pharmaceuticals Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Anebulo Pharmaceuticals is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Anebulo Pharmaceuticals is generally in the same direction as the market. If Beta > 1 Anebulo Pharmaceuticals moves generally in the same direction as, but more than the movement of the benchmark.
About Anebulo Pharmaceuticals Financials
What exactly are Anebulo Pharmaceuticals Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Anebulo Pharmaceuticals' income statement, its balance sheet, and the statement of cash flows. Potential Anebulo Pharmaceuticals investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Anebulo Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Anebulo Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Anebulo Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Steps to analyze Anebulo Pharmaceuticals Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Anebulo Pharmaceuticals is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Anebulo has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Anebulo Pharmaceuticals' financials are consistent with your investment objective using the following steps:- Review Anebulo Pharmaceuticals' balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Anebulo Pharmaceuticals' liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Anebulo Pharmaceuticals' financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Anebulo Pharmaceuticals' stock is overvalued or undervalued.
Today, most investors in Anebulo Pharmaceuticals Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Anebulo Pharmaceuticals' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Anebulo Pharmaceuticals growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Anebulo Pharmaceuticals May 1, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Anebulo Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Anebulo Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Anebulo Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Anebulo Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Anebulo Pharmaceuticals's daily price indicators and compare them against related drivers.
| Downside Deviation | 4.45 | |||
| Information Ratio | 0.0748 | |||
| Maximum Drawdown | 20.75 | |||
| Value At Risk | (5.51) | |||
| Potential Upside | 6.2 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anebulo Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. For information on how to trade Anebulo Stock refer to our How to Trade Anebulo Stock guide.Note that the Anebulo Pharmaceuticals information on this page should be used as a complementary analysis to other Anebulo Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Complementary Tools for Anebulo Stock analysis
When running Anebulo Pharmaceuticals' price analysis, check to measure Anebulo Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anebulo Pharmaceuticals is operating at the current time. Most of Anebulo Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Anebulo Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anebulo Pharmaceuticals' price. Additionally, you may evaluate how the addition of Anebulo Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |
Is Anebulo Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anebulo Pharmaceuticals. If investors know Anebulo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anebulo Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.41) | Return On Assets (0.55) | Return On Equity (0.95) |
The market value of Anebulo Pharmaceuticals is measured differently than its book value, which is the value of Anebulo that is recorded on the company's balance sheet. Investors also form their own opinion of Anebulo Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Anebulo Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anebulo Pharmaceuticals' market value can be influenced by many factors that don't directly affect Anebulo Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anebulo Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Anebulo Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anebulo Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.